ReviewPharmacoepidemiology and drug safety2025

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus.

Chinyere Aloke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.